Friday 22 August 2014
 
»
Tag
 
»
Onglyza

Onglyza reduces blood sugar levels: study

Pharmaceutical companies Bristol-Myers Squibb and AstraZeneca have announced results from an investigational phase 3b clinical study of use of Onglyza (saxagliptin) in diabetic patients. The study was based on the addition of Onglyza (saxa

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads